Imperva Inc (IMPV) Expected to Announce Quarterly Sales of $82.29 Million
Wall Street analysts expect Imperva Inc (NYSE:IMPV) to post $82.29 million in sales for the current fiscal quarter, Zacks reports. Seven analysts have issued estimates for Imperva’s earnings. The highest sales estimate is $82.98 million and the lowest is $82.01 million. Imperva reported sales of $68.41 million during the same quarter last year, which would suggest a positive year-over-year growth rate of 20.3%. The company is expected to issue its next quarterly earnings results on Thursday, November 2nd.
According to Zacks, analysts expect that Imperva will report full year sales of $82.29 million for the current financial year, with estimates ranging from $320.90 million to $322.76 million. For the next financial year, analysts anticipate that the firm will post sales of $379.23 million per share, with estimates ranging from $369.00 million to $386.30 million. Zacks’ sales averages are a mean average based on a survey of research analysts that cover Imperva.
Imperva (NYSE:IMPV) last issued its quarterly earnings results on Thursday, July 27th. The software maker reported ($0.10) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.05 by ($0.15). The company had revenue of $74.44 million during the quarter, compared to the consensus estimate of $74.30 million. Imperva had a negative return on equity of 5.00% and a negative net margin of 4.69%. The firm’s quarterly revenue was up 28.6% on a year-over-year basis. During the same quarter last year, the firm posted ($0.23) EPS.
Several research firms have recently weighed in on IMPV. Evercore ISI set a $56.00 price objective on Imperva and gave the company a “buy” rating in a research report on Thursday, August 10th. BidaskClub cut Imperva from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, July 5th. Monness Crespi & Hardt increased their price objective on Imperva from $55.00 to $57.00 and gave the company a “buy” rating in a research report on Friday, July 28th. Piper Jaffray Companies set a $58.00 price objective on Imperva and gave the company a “buy” rating in a research report on Monday, August 28th. Finally, Stifel Nicolaus reissued a “hold” rating and issued a $47.00 price objective on shares of Imperva in a research report on Friday, July 14th. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Imperva has an average rating of “Buy” and an average price target of $52.97.
Shares of Imperva (NYSE:IMPV) opened at 44.10 on Friday. The company’s market cap is $1.49 billion. Imperva has a 52 week low of $34.40 and a 52 week high of $57.24. The company has a 50 day moving average of $44.19 and a 200-day moving average of $45.49.
In related news, Director Anthony J. Bettencourt sold 99,598 shares of the firm’s stock in a transaction on Thursday, August 24th. The stock was sold at an average price of $43.59, for a total value of $4,341,476.82. Following the completion of the transaction, the director now directly owns 99,598 shares of the company’s stock, valued at $4,341,476.82. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 2.20% of the stock is owned by company insiders.
A number of hedge funds have recently modified their holdings of IMPV. Teachers Advisors LLC lifted its position in Imperva by 4.4% in the fourth quarter. Teachers Advisors LLC now owns 47,262 shares of the software maker’s stock worth $1,815,000 after purchasing an additional 1,972 shares during the period. Wells Fargo & Company MN lifted its position in Imperva by 33.2% in the first quarter. Wells Fargo & Company MN now owns 102,511 shares of the software maker’s stock worth $4,208,000 after purchasing an additional 25,530 shares during the period. Chicago Equity Partners LLC bought a new position in Imperva in the first quarter worth $444,000. First Trust Advisors LP lifted its position in Imperva by 35.2% in the first quarter. First Trust Advisors LP now owns 154,591 shares of the software maker’s stock worth $6,346,000 after purchasing an additional 40,263 shares during the period. Finally, US Bancorp DE lifted its position in Imperva by 142.3% in the first quarter. US Bancorp DE now owns 5,386 shares of the software maker’s stock worth $221,000 after purchasing an additional 3,163 shares during the period. 92.72% of the stock is owned by hedge funds and other institutional investors.
Imperva Company Profile
Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Imperva Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc and related companies with MarketBeat.com's FREE daily email newsletter.